期刊
MOLECULES
卷 23, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/molecules23010024
关键词
quinazoline; thiourea; sorafenib; TK inhibitor; molecular docking
资金
- Taishan Scholar Project
- National Natural Science Foundation of China [81202038, 81728020]
- Key Research Project of Shandong Province [2017GSF18177]
- Ph.D. Programs Foundation of Yantai University [YX13B03-2013]
Both EGFR and VEGFR-2 play a critical role in tumor growth, angiogenesis and metastasis, and targeting EGFR and VEGFR-2 simultaneously represents a promising approach to cancer treatment. In this work, a series of novel quinazoline- and thiourea-containing sorafenib analogs (10a-v) were designed and synthesized as EGFR and VEGFR-2 dual TK inhibitors. Their in vitro enzymatic inhibitory activities against EGFR and VEGFR-2, and antiproliferative activities against HCT-116, MCF-7 and B16 cell lines were evaluated and described. Most of the compounds showed potent activities against both cell lines and TK kinases. Compounds 10b and 10q which exhibited the most potent inhibitory activities against EGFR (IC50 = 0.02 mu M and 0.01 mu M, respectively), VEGFR-2 (IC50 = 0.05 mu M and 0.08 mu M, respectively), and good antiproliferative activities, also displayed competitive anti-tumor activities than sorafenib in vivo by B16 melanoma xenograft model test.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据